Literature DB >> 8019967

A new B-cell line showing a complex translocation (8;14;18) and BCL2 rearrangement.

R B van Ooteghem1, E M Smit, A Beishuizen, A C Lambrechts, M vd Blij-Philipsen, T J Smilde, A Hagemeijer.   

Abstract

A cell line named ROS-50 (Rotterdam suspension cell line no. 50) has been established from peripheral blood of a 69-year-old male with acute lymphoblastic leukemia (FAB type L3). Among the aberrations, cytogenetic analysis showed the presence of 14q+, 18q-, and two 8q- marker chromosomes. With fluorescence in situ hybridization (FISH) we characterized the chromosomal translocations, t(8;14) and t(14;18), in which the same chromosome 14 is involved. PCR analysis demonstrated the presence of on IGH-BCL2 rearrangement with a breakpoint in the minor cluster region (mcr) confirming the t(14;18) characteristic for follicular lymphoma. Additional studies showed high expression of BCL2 protein, an early B-cell immunophenotype, and an unusual pattern of IGH gene rearrangement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019967     DOI: 10.1016/0165-4608(94)90003-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

3.  Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.

Authors:  Naoto Tomita; Mami Tokunaka; Naoya Nakamura; Kengo Takeuchi; Junki Koike; Shigeki Motomura; Ko Miyamoto; Ako Kikuchi; Rie Hyo; Yoshihiro Yakushijin; Yasufumi Masaki; Soichiro Fujii; Takamasa Hayashi; Yoshiaki Ishigatsubo; Ikuo Miura
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

Review 4.  t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.

Authors:  Delong Liu; Josif Shimonov; Suneeta Primanneni; Yongrong Lai; Tauseef Ahmed; Karen Seiter
Journal:  Mol Cancer       Date:  2007-06-04       Impact factor: 27.401

5.  De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review.

Authors:  Akiko Uchida; Yasushi Isobe; Yu Uemura; Yuji Nishio; Hirotaka Sakai; Masayuki Kato; Kaori Otsubo; Masahiro Hoshikawa; Masayuki Takagi; Ikuo Miura
Journal:  BMC Clin Pathol       Date:  2017-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.